Literature DB >> 11520762

Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy.

U E Schnurrbusch1, K Welt, L C Horn, P Wiedemann, S Wolf.   

Abstract

AIM: To investigate effects of photodynamic therapy (PDT) on human choroidal neovascularisation (CNV).
METHODS: Two patients with recurrences after PDT with verteporfin underwent surgical extraction of the CNV. Immediately after surgical excision the subfoveal neovascular membranes were divided for light microscopic and for electron microscopic processing. For light microscopy tissues were embedded in paraffin. Sections were stained with haematoxylin and eosin, and the periodic acid Schiff (PAS) reaction was performed to determine histological diagnosis and to ensure tissue quality. For electron microscopy the specimens were fixed in glutaraldehyde and embedded in epoxy resin. Semithin sections were stained with uranyl acetate and lead citrate and examined with a transmission electron microscope.
RESULTS: Light microscopy showed thick fibrovascular membranes in both cases. On the outer surface remnants of retinal pigment epithelial cells resting on thickened inner aspect of Bruch's membrane were found. On the retinal side some outer segments were found. The membrane showed areas with irregularly shaped vessels. Electron photomicrographs showed occluded vessels within the CNV containing thrombotic masses and/or ultrastructural damage of the neovascular endothelium. Most of the vessels presented regressive changes with vacuolisation and fragmentation of the neovascular endothelium accompanied by disintegration of the endothelial cell layer. Extravasation of red blood cells was observed. Occasionally, vessels with normal endothelium containing intact red blood cells were observed. Some vessels contained immature endothelial cells. At some locations the retinal pigment epithelium cells (RPE) were metaplastic showing highly vacuolised cytoplasm.
CONCLUSIONS: These findings suggest that the evidence of fluorescein leakage from the CNV and enlargement of the neovascular complex following PDT could be related to new vessel growth and recanalisation of occluded vessels. Additionally, RPE disturbances were observed in the specimens. This finding may be related to the original pathology or could indicate that PDT treatment may result in RPE atrophy.

Entities:  

Mesh:

Year:  2001        PMID: 11520762      PMCID: PMC1724112          DOI: 10.1136/bjo.85.9.1086

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

1.  Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration.

Authors:  H E Grossniklaus; J A Martinez; V B Brown; H M Lambert; P Sternberg; A Capone; T M Aaberg; P F Lopez
Journal:  Am J Ophthalmol       Date:  1992-10-15       Impact factor: 5.258

2.  Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration.

Authors:  P F Lopez; H E Grossniklaus; H M Lambert; T M Aaberg; A Capone; P Sternberg; N L'Hernault
Journal:  Am J Ophthalmol       Date:  1991-12-15       Impact factor: 5.258

3.  Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1994-09-15       Impact factor: 5.258

4.  Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation.

Authors:  B A Lafaut; K U Bartz-Schmidt; C Vanden Broecke; S Aisenbrey; J J De Laey; K Heimann
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

5.  Ultrastructural features of surgically excised idiopathic subfoveal neovascular membranes.

Authors:  J W Thomas; H E Grossniklaus; H M Lambert; T M Aaberg; N L'Hernault
Journal:  Retina       Date:  1993       Impact factor: 4.256

6.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Authors:  U Schmidt-Erfurth; J W Miller; M Sickenberg; H Laqua; I Barbazetto; E S Gragoudas; L Zografos; B Piguet; C J Pournaras; G Donati; A M Lane; R Birngruber; H van den Berg; H A Strong; U Manjuris; T Gray; M Fsadni; N M Bressler
Journal:  Arch Ophthalmol       Date:  1999-09

7.  Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin.

Authors:  U Schmidt-Erfurth; W Bauman; E Gragoudas; T J Flotte; N A Michaud; R Birngruber; T Hasan
Journal:  Ophthalmology       Date:  1994-01       Impact factor: 12.079

Review 8.  Age-related macular degeneration.

Authors:  N M Bressler; S B Bressler; S L Fine
Journal:  Surv Ophthalmol       Date:  1988 May-Jun       Impact factor: 6.048

9.  Clinicopathologic features of surgically excised choroidal neovascular membranes.

Authors:  H E Grossniklaus; A K Hutchinson; A Capone; J Woolfson; H M Lambert
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

10.  Clinicopathologic correlation of choroidal neovascularization demonstrated by indocyanine green angiography in a patient with retention of good vision for almost four years.

Authors:  T S Chang; K B Freund; Z de la Cruz; L A Yannuzzi; W R Green
Journal:  Retina       Date:  1994       Impact factor: 4.256

View more
  23 in total

1.  The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularization.

Authors:  Libin Jiang; Chenjin Jin; Feng Wen; Shizhou Huang; Dezheng Wu; Lezheng Wu
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

2.  Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.

Authors:  M B Parodi; S Da Pozzo; G Ravalico
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

3.  Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings.

Authors:  P Stanga; P Hiscott; K Li; D Wong
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

4.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

5.  Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.

Authors:  M Inoue; A Arakawa; S Yamane; K Kadonosono
Journal:  Eye (Lond)       Date:  2013-08-23       Impact factor: 3.775

6.  Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life.

Authors:  Alex W Hewitt; V Swetha Jeganathan; Juanita E Kidd; Konrad Pesudovs; Nitin Verma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

7.  Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Authors:  Marco Antonio Bonini Filho; Talisa E de Carlo; Daniela Ferrara; Mehreen Adhi; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

8.  [Transient visual decrease after photodynamic therapy].

Authors:  S Mennel; N Hausmann; C H Meyer; S Hörle; S Peter
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

Review 9.  Spotlight on verteporfin in subfoveal choroidal neovascularisation.

Authors:  Susan J Keam; Lesley J Scott; Monique P Curran
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Authors:  Dimitrios A Karagiannis; Ioannis D Ladas; Efstratios Parikakis; Ilias Georgalas; Athanasios Kotsolis; Giorgos Amariotakis; Vasileios Soumplis; Panagiotis Mitropoulos
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.